|
BAT2L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34849999999343E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.938900E-03 |
| Normal-vs-Stage2 |
4.518200E-02 |
| Normal-vs-Stage3 |
5.919000E-03 |
| Normal-vs-Stage4 |
1.254430E-01 |
| Stage1-vs-Stage2 |
3.318000E-01 |
| Stage1-vs-Stage3 |
4.848000E-02 |
| Stage1-vs-Stage4 |
3.401800E-01 |
| Stage2-vs-Stage3 |
2.132600E-01 |
| Stage2-vs-Stage4 |
5.504200E-01 |
| Stage3-vs-Stage4 |
7.048600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.754850E-04 |
| Normal-vs-AfricanAmerican |
2.419000E-03 |
| Normal-vs-Asian |
1.856600E-01 |
| Caucasian-vs-AfricanAmerican |
9.536000E-01 |
| Caucasian-vs-Asian |
8.327600E-01 |
| AfricanAmerican-vs-Asian |
7.825200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.586200E-04 |
| Normal-vs-Female |
3.67210000000728E-05 |
| Male-vs-Female |
4.681800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.149900E-02 |
| Normal-vs-Extreme_Weight |
3.372300E-02 |
| Normal-vs-Obese |
2.399100E-04 |
| Normal-vs-Extreme_Obese |
5.176600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.791000E-01 |
| Normal_Weight-vs-Obese |
6.106400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.539390E-01 |
| Extreme_Weight-vs-Obese |
3.290400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.552800E-01 |
| Obese-vs-Extreme_Obese |
3.553600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.001700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.37060000005018E-06 |
| Normal-vs-Age(61-80Yrs) |
2.116000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.502000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.747370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.289980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.416600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.113780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.194100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.310800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.20630000000211E-05 |
| Normal-VS-Type2 PRCC |
4.972200E-02 |
| Normal-VS-KIRP CIMP |
9.916400E-03 |
| Normal-VS-Unclassified PRCC |
3.479900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.614000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.195500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.319000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.065600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.916200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.867000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.177700E-02 |
| Normal-vs-N1 |
1.820530E-03 |
| Normal-vs-N2 |
2.371200E-04 |
| N0-vs-N1 |
1.359920E-02 |
| N0-vs-N2 |
1.318370E-01 |
| N1-vs-N2 |
7.167000E-01 |
|
|
